Clozapine for tardive dyskinesia in adolescents

Brain and Development

Volumn 17, Issue 3, 1995, Pages 213-215

  Levkovitch, Yechiel ^a   Kronenberg, Julia ^a   Kayser, Nehemia ^a   Zvyagelski, Michael ^a   Gaoni, Bracha ^a   Gadoth, Natan ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Adolescence; Clozapine; Neuroleptic; Tardive dyskinesia

Indexed keywords

CHLORPROMAZINE; CLOTIAPINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; PERICIAZINE;

ADOLESCENT; ARTICLE; CASE REPORT; DROWSINESS; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MENTAL DISEASE; SALIVATION; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CASE REPORT; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; HUMAN; MALE; SCHIZOPHRENIA;

EID: 0029007890     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/0387-7604(95)00034-9     Document Type: Article

References (18)

1. Clozapine effects on tardive dyskinesia
2. Pediatric psychopharmacology
3. Adverse effects of pharmacotherapy in childhood psychosis
4. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents
5. Effect of clozapine in severe tardive dyskinesia: a case report
6. Clozapine in tardive dyskinesia
7. Drug trials in persistent dyskinesia
8. Clozapine in the treatment of tardive dyskinesia: an interim report
9. The effects of clozapine on tardive dyskinesia
10. Clozapine and jaw dyskinesia: a case report
11. A rating scale for tardive dyskinesia
12. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling
13. The trial use of clozapine for abnormal involuntary movement disorders
14. Paradoxical response to dopamine agonists in tardive dyskinesia
15. Tardive dyskinesia during and following treatment with haloperidol, periden, thioridazine, and clozapine
16. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity and treatment-resistant psychosis
17. Clozapine: neuroleptic-induced EPS and tardive dyskinesia